Detalles de la búsqueda
1.
Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients.
Cancer Control
; 30: 10732748221141672, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814068
2.
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
Ann Surg Oncol
; 26(8): 2409-2416, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065958
3.
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
Breast Cancer Res Treat
; 170(1): 69-76, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516374
4.
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Breast Cancer Res Treat
; 148(1): 91-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253173
5.
Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
Ann Surg Oncol
; 21(4): 1254-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356798
6.
Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
Front Oncol
; 13: 1181069, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37427099
7.
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant Chemotherapy.
Cancer Res Treat
; 55(2): 542-550, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36097802
8.
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer.
Cancers (Basel)
; 15(18)2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760420
9.
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: the Korean Cancer Study Group BR 07-01.
Breast Cancer Res Treat
; 132(2): 589-600, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22094934
10.
A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer.
Invest New Drugs
; 30(5): 1972-7, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22006161
11.
Predictive factors of pathologic complete response and clinical tumor progression after preoperative chemotherapy in patients with stage II and III breast cancer.
Invest New Drugs
; 30(1): 408-16, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20922557
12.
Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.
Breast Cancer Res
; 13(2): R34, 2011 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450081
13.
Peritoneal lymphomatosis confounded by prior history of colon cancer: a case report.
BMC Cancer
; 11: 276, 2011 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21708008
14.
Accumulation of p53 determined by immunohistochemistry as a prognostic marker in node negative breast cancer; analysis according to St Gallen consensus and intrinsic subtypes.
J Surg Oncol
; 103(3): 207-11, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21337548
15.
Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score.
NPJ Breast Cancer
; 7(1): 13, 2021 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33579950
16.
Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability.
J Breast Cancer
; 24(3): 266-279, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128367
17.
Standardized pathology report for breast cancer.
J Pathol Transl Med
; 55(1): 1-15, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33461287
18.
Standardized Pathology Report for Breast Cancer.
J Breast Cancer
; 24(1): 1-21, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33634617
19.
A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification.
J Pathol Transl Med
; 55(6): 380-387, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34614346
20.
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
Breast Cancer Res Treat
; 123(1): 125-8, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19916047